Insulin Infusion Sets and Continuous Glucose Monitoring Sensors: Where the Artificial Pancreas Meets the Patient
Forlenza Gregory P.. Diabetes Technology & Therapeutics. April 2017, 19(4): 206-208. doi:10.1089/dia.2017.0048.
An Amperometric Glucose Sensor Integrated into an Insulin Delivery Cannula: In Vitro and In Vivo Evaluation has been published in Volume: 19 Issue 4: April 1, 2017 of Diabetes Technology & Therapeutics.
Thank you to all the PDT team and our OHSU partners for your hard work!
GRANT #1: thanks to the NIH (National Institute of Diabetes, Digestive and Kidney Diseases)
Development of a dual-function glucose sensing and hormone delivery catheter for persons with Type 1 Diabetes (Single Indicating Electrode Sensing Catheter)
On September 18, 2012, the NIH (NIDDK) awarded a grant in the amount of $292,000 over two years to Pacific DT (doing business as EmbedRF, Inc). The principal investigators are Robert S. Cargill and W. Kenneth Ward. The basic idea is to develop a flexible or rigid catheter that can be used as a standard insulin infusion catheter but also has the benefit of measuring glucose continuously by sensing materials placed on the outer surface of the catheter.
GRANT #2: thanks to the Helmsley Trust
Development of a dual-function glucose sensing and hormone delivery catheter for use within an artificial pancreas (multiple indicating electrode sensing catheter). This project deals with a multiple sensing units in order to utilize the benefit of redundancy. In other words the device to be created in this project will have more than one sensing element in order to have more accuracy in the measurement of glucose.
On January 15, 2013, the PDT team started work on this project, also a two year grant. This project is being generously funded by the Helmsley Trust and the grant amount is $999,800. The principal investigators are W. Kenneth Ward and Robert S. Cargill.
GRANT #3: Thanks to NIH — NIDDK
This grant extends from Sept 2013 to the end of August, 2014. In this project ($222,000), PDT will create a wearable device that will integrate three components: (A) the electronic sensor module, (B) the insulin infusion connector, and (C) the sensing catheter. This structure will provide connections to the multiple indicating electrodes and single reference electrode that emanate from the sensing catheter. The principal investigator is Robert S. Cargill, co-investigator W. Kenneth Ward.